PNV ASX Chart
Snapshot
Polynovo Limited (PNV) is involved in the development of innovative medical devices for a number of medical applications, utilising the patented bioabsorbable polymer technology NovoSorb. The Company can manufacture NovoSorb polymer devices with the ability to elute drugs, antimicrobials as well as be expressed in a variety of physical formats including, Films, foam, Coatings/sprays, Fibers, Plastic structures, Biologic carrier.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2024 YTD | |
1 Year | |
vs Sector (1yr) | +84.43% |
vs ASX 200 (1yr) | +86.52% |
Announcements
Corporate Overview
Corporate Details
Head Office | Port Melbourne VIC 3207 |
Website | www.polynovo.com |
Registry | Computershare |
Auditor | Ernst & Young |
Date Listed | 26 Nov 1998 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
28/10/2024 | AGM |
25/02/2025 | Report (Interim) |
22/08/2025 | Report (Prelim) |
22/08/2025 | Report (Annual) |
Former Company Names
- Calzada Limited (CZD), 28/11/2014
- Metabolic Pharmaceuticals Limited (MBP) on 30/11/2009
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
PNV directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of PNV directors.
Shareholder Info
Substantial Shareholders
No Substantial Shareholders for PNV in our database.
Shareholders Buying
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
20-09-24 | State Street Corporation and subsidiaries | 35,159,423 | -- | 5.09 |
13-09-24 | State Street Corporation and subsidiaries | 35,513,404 | -- | 5.14 |
18-06-24 | Vanguard Group | 34,514,142 | -- | 5.00 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
Date | Name | Sold | Previous % | New % |
---|---|---|---|---|
24-09-24 | State Street Corporation and subsidiaries | 35,159,423 | 5.09 | -- |
16-09-24 | State Street Corporation and subsidiaries | 35,513,404 | 5.14 | -- |
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2024 | $2.45 | 28 June |
2023 | $1.55 | 30 June |
2022 | $1.36 | 30 June |
2021 | $2.82 | 30 June |
2020 | $2.54 | 30 June |
2019 | $1.54 | 28 June |
2018 | $0.535 | 29 June |
2017 | $0.21 | 30 June |
2016 | $0.28 | 30 June |
2015 | $0.09 | 30 June |
2014 | $0.105 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.